US20030125532A1 - Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure - Google Patents

Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure Download PDF

Info

Publication number
US20030125532A1
US20030125532A1 US10/305,108 US30510802A US2003125532A1 US 20030125532 A1 US20030125532 A1 US 20030125532A1 US 30510802 A US30510802 A US 30510802A US 2003125532 A1 US2003125532 A1 US 2003125532A1
Authority
US
United States
Prior art keywords
chitosan
chitin
derivative
hydrogel
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/305,108
Inventor
Fumio Yoshii
Naotsugu Nagasawa
Tamikazu Kume
Hiroshi Mitomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Atomic Energy Agency
Original Assignee
Japan Atomic Energy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Atomic Energy Research Institute filed Critical Japan Atomic Energy Research Institute
Assigned to JAPAN ATOMIC ENERGY RESEARCH INSTITUTE reassignment JAPAN ATOMIC ENERGY RESEARCH INSTITUTE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KUME, TAMIKAZU, MITOMO, HIROSHI, NAGASAWA, NAOTSUGU, YOSHII, FUMIO
Publication of US20030125532A1 publication Critical patent/US20030125532A1/en
Priority to US11/028,203 priority Critical patent/US7307157B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Definitions

  • This invention relates to a process for producing chitin derivatives and/or chitosan derivatives with a crosslinked structure by adding purified water to chitin derivatives and/or chitosan derivatives, kneading the mixture well and applying an ionizing radiation to the kneaded mixture.
  • the chitin derivatives having a crosslinked structure are hydrogels and the chitosan derivatives having a crosslinked structure are hydrogels having antimicrobial activity.
  • Hydrogels can hold a large amount of water within the three-dimensional network structure generated by crosslinking with radiation. The retained water will not seep out under slight pressure. Such hydrogels are already in use as disposable diapers and as humectants in cosmetics.
  • Hydrogels can be easily obtained by applying an ionizing radiation to aqueous solutions of polyethylene oxides, poly(vinyl alcohol), polyacrylamides, polyvinylpyrrolidone, etc. Being capable of absorbing and holding a large amount of water, hydrogels are used in medical and cosmetics fields as sanitary products (e.g. disposable diapers) and humectants. These hydrogels are primarily made of poly(sodium acrylate) based materials. Used hydrogels are disposed of by incineration, so if they are treated massively, the temperature in the incinerator will drop to cause a potential problem of producing dioxins.
  • hydrogels that decompose in the soil to exert no environmental impact, as exemplified by poly(sodium glutamate) and poly(sodium aspartate) having irradiation-generated crosslinks.
  • Formaldehyde and glutaraldehyde are conventionally used to create chemical crosslinks in chitin and chitosan. However, since the aldehydes contaminate the working environment or the residual aldehydes may irritate the skin, a safer method of crosslinking is desired.
  • Hydrogels produced by crosslinking water-soluble polymers absorb a large amount of water, so they are used in sanitary products such as disposable diapers.
  • zeolite incorporating antimicrobes such as silver are added as an antimicrobial agent.
  • accumulation of silver is not preferred from the viewpoint of health. It is therefore required to develop high-molecular weight polymers that themselves have antimicrobial activity.
  • Chitosan has positive electric charges, so they bind to negatively charged microorganisms and exhibit antimicrobial activity to inhibit microbial growth.
  • the applicable scope of chitin and chitosan which are currently discarded will expand and their added value will further increase if a safer method of their crosslinking is found and if hydrogels that themselves have antimicrobial activity are developed.
  • chitin and chitosan have no compatible solvents and if they are irradiated in a solid state, marked decomposition will occur. Therefore, chitin and chitosan are difficult to process into films or fibers and it is also difficult to crosslink them by radiation.
  • FIG. 1A is a photo showing that a PVA hydrogel has no antimicrobial activity against E. coli;
  • FIG. 1B is a photo showing the antimicrobial activity of a CM-chitosan hydrogel with a gel fraction of 40% against E. coli;
  • FIG. 1C is a photo showing the antimicrobial activity of a CM-chitosan hydrogel with a gel fraction of 25% against E. coli.
  • the hydrogels of chitin and chitosan derivatives according to the invention are synthesized by the following method. Chitin and chitosan derivatives having different degrees of substitution are kneaded well with purified water to make a concentrated paste that is thick enough not to flow out if the container is tilted.
  • the paste is put into a poly(vinylidene chloride) bag, evacuated, heat sealed and exposed to electron beams. Before irradiation, the paste was soft but upon irradiation, it turned to a rubbery and elastic gel. In order to perform radiation-induced crosslinking, the paste must have a concentration of at least 10%, preferably between 30% and 50%.
  • the ionizing radiation can be ⁇ -rays, electron beams or X-rays.
  • the crosslinking dose is 0.5 ⁇ 1,000 kGy, preferably 5 ⁇ 300 kGy.
  • chitin and chitosan derivatives that are soluble in water can be used in the invention. Higher degrees of substitution are preferred since they increase the affinity for water and, hence, provide thicker pastes. The most preferred degree of substitution is 0.3 ⁇ 0.9.
  • Chitin is extracted from the outer covering of crustaceans such as shrimps and crabs by deproteinization and chitosan is obtained from chitin by deacetylation. Since chitin and chitosan are comparatively cheap materials, they are preferred as materials for the synthesis of derivatives.
  • Examples of the chitin derivatives of the invention include CM-chitin, carboxyethyl-chitin, methyl-chitin, ethyl-chitin, hydroxyethyl-chitin, hydroxypropyl-chitin, oxidized chitin, acetyl-chitin, aminoalkyl-chitin and allyl-chitin.
  • Examples of the chitosan derivatives of the invention include CM-chitosan, carboxyethyl-chitosan, methyl-chitosan, ethyl-chitosan, hydroxyethyl-chitosan, hydroxypropyl-chitosan, oxidized chitosan, acetyl-chitosan, aminoalkyl-chitosan and allyl-chitosan.
  • the ionizing radiation are ⁇ -rays from cobalt-60 and electron beams from an accelerator.
  • the most preferred electron accelerator is one of medium to high energy types that have acceleration voltages of at least 1 MeV and can irradiate thick sheets. If a yet-to-be irradiated sample is pressurized to form a film, even the electron beams from a low-energy electron accelerator having an acceleration voltage of less than 1 MeV can penetrate the sample and the intended gel can be formed by radiation-induced crosslinking.
  • the top surface of the sample is desirably covered with a film of plastics such as polyester.
  • Gel fraction is determined as follows. The gel formed by irradiation is freeze-dried and put into a vacuum dryer where it is dried at 50° C. until its weight becomes constant. The dried sample is put into a cage of stainless steel wire having a fineness of 200 mesh and immersed in a large volume of water for 48 hours. The uncrosslinked soluble component of the sample has moved into the aqueous phase, leaving only the gelled component in the cage. The stainless steel cage holding the gel is immersed in methanol for 1 hour, recovered and then dried at 50° C. for 24 hours. Gel fraction is calculated by the following equation:
  • the antimicrobial activity of the hydrogel is determined as follows. An irradiated paste of sample is immersed in purified water for 48 hours in order to remove the uncrosslinked sol. The remaining gel is cut to a specified size and put into a Petri dish containing an agar medium plated with E. coli . As time passes, E. coli grows. A clear zone forming around the hydrogel indicates an inhibition of E. coli growth and one may conclude that the hydrogel has antimicrobial activity.
  • Chitosan has antimicrobial activity whose intensity increases if the molecular weight of chitosan is decreased by irradiation.
  • chitosan dissolves only in dilute acids and cannot be easily processed into hydrogel or sheet.
  • a hydrogel having antimicrobial activity could successfully be produced from chitosan derivatives by crosslinking them with radiation. By radiation-induced crosslinking, the hydrogel can be obtained in blocks, sheets or various other shapes and may find use in the following applications.
  • the hydrogel of chitosan derivatives or their blends with other hydrogels may be used as wound dressings that are applied to cover wounds due to injury or burn and promote their healing.
  • Wound dressings of wet type have recently been put on the market since burn and wounds such as bedsores of the elderly can heal rapidly in a wet environment and the healed wound has a smooth surface.
  • the wound dressing using the hydrogel of chitosan derivatives according to the invention is different from the conventional wet type wound dressing since the hydrogel itself has antimicrobial activity and there is no need to add any antimicrobes.
  • the antimicrobial hydrogel of the invention can be gel spun into fibers having antimicrobial activity.
  • the hydrogel may be deprived of water by evaporation and can subsequently be shaped into a film, which is attached to the surfaces of various substrates to thereby make antimicrobial articles that can prevent the growth of molds and other deleterious microorganisms.
  • the antimicrobial hydrogel of the invention has potential application in various fields.
  • CM-chitin was used; it had a degree of substitution of 0.49, a molecular weight of 2.82 ⁇ 10 4 and a degree of deacetylation of 17.7%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 10, 20, 30, 40 and 50%, which were irradiated with electron beams to a dose of 50 kGy. The results are shown in Table 1, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel.
  • the CM-chitin preferably has a concentration of 20-40%.
  • TABLE 1 Gel fractions and the degrees of swell in the case of exposing 50 kGy of electron beams to CM-chitin (degree of substitution: 0.49) at varying concentrations Concentration (%) 10 20 30 40 50 of CM-chitin Gel fraction (%) 31 48 50 52 28 Degree of swell 111 56 34 21 93 (g H 2 O/1 g dry gel
  • CM-chitin was used; it had a degree of substitution of 0.83, a molecular weight of 2.93 ⁇ 10 4 and a degree of deacetylation of 31.4%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 10, 20, 30, 40 and 50%, which were irradiated with electron beams to a dose of 50 kGy. The results are shown in Table 2, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel.
  • the CM-chitin preferably has a concentration of 20 ⁇ 40%.
  • TABLE 2 Gel fractions and the degrees of swell in the case of exposing 50 kGy of electron beams to CM-chitin (degree of substitution: 0.83) at varying concentrations Concentration (%) 10 20 30 40 50 of CM-chitin Gel fraction (%) 41 52 59 61 46 Degree of swell 148 58 20 14 120 (g H 2 O/1 g dry gel
  • CM-chitin Two kinds were used; one of them had a degree of substitution of 0.49, a molecular weight of 2.82 ⁇ 10 4 and a degree of deacetylation of 17.7%; the other had a degree of substitution of 0.83, a molecular weight of 2.93 ⁇ 10 4 and a degree of deacetylation of 31.4%.
  • Each sample was exposed to electron beams from an accelerator in two states, solid at room temperature and as a dilute ( ⁇ 5%) aqueous solution, until the dose was 200 kGy. In either case, the molecular weights of the samples decreased to such an extent that they were readily soluble in water; however, no water-insoluble gel component formed and no crosslinking occurred under the conditions employed.
  • CM-chitosan was used; it had a degree of substitution of 0.91, a molecular weight of 3.1 ⁇ 10 4 and a degree of deacetylation of 84.0%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 20, 25, 35 and 50%, which were irradiated with electron beams to a dose of 100 kGy. The results are shown in Table 3, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel. For crosslinking, the CM-chitosan preferably has a concentration of 25-35%.
  • CM-chitosan hydrogel that was prepared by exposing electron beams to a paste of 35% CM-chitosan to a dose of 150 kGy. The sample was immersed in purified water for 48 hours to remove the sol which was a soluble component. The thus prepared CM-chitosan hydrogel had a gel fraction of 40%.
  • CM-chitosan was used; it had a degree of deacetylation of 84.0%, a degree of substitution (degree of carboxymethylation) of 0.91 and a viscosity average molecular weight of 3.1 ⁇ 10 4 .
  • a CM-chitosan hydrogel was prepared by exposing electron beams to a paste of 35% CM-chitosan to a dose of 80 kGy. The sample was immersed in purified water for 48 hours to remove the sol which was a soluble component. The thus prepared CM-chitosan hydrogel had a gel fraction of 25%.
  • Example 3 As in Example 3, the hydrogel was cut to a disk with a diameter of 10 mm and placed on an agar medium plated with 1 ⁇ 10 6 E. coli cells/mL which were cultured at 37° C. As FIG. 1C shows, a clear zone about 5 mm wide formed around the hydrogel by inhibiting the growth of E. coli . Growth of E. coli occurred in areas of the medium other than around the hydrogel disk.
  • CM-chitosan was used; it had a degree of substitution of 0.91, a molecular weight of 3.1 ⁇ 10 4 and a degree of deacetylation of 84.0%.
  • the sample was exposed to electron beams from an accelerator in two states, solid at room temperature and as a dilute ( ⁇ 10%) aqueous solution, until the dose was 300 kGy. In either case, the molecular weight of the sample decreased to such an extent that it was readily soluble in water; however, no water-insoluble gel component formed and no crosslinking occurred under the conditions employed.
  • a hydrogel prepared by irradiating an aqueous solution of 10% poly(vinyl alcohol) was tested for its antimicrobial activity.
  • a disk of the PVA hydrogel with a diameter of 10 mm was placed on an agar medium plated with 1 ⁇ 10 6 E. coli cells/mL which were cultured at 37° C.
  • FIG. 1A shows, E. coli grew uniformly around the hydrogel with the lapse of time. No clear zone formed around the hydrogel, clearly demonstrating the absence of its antimicrobial activity.
  • the white bands in the center of FIG. 1A are due to the reflection of light from the clear hydrogel that occurred when the picture was taken.
  • the CM-chitin has acetyl groups, so after being crosslinked, it can be reacted with such acetyl groups to create a hydrogel having a new property.
  • the CM-chitosan hydrogel is a unique gel which itself has antimicrobial activity.
  • the CM-chitosan hydrogel can be used as a wound dressing which, when applied to a wound, can prevent the ingress of germs to promote the healing of the wound.
  • the CM-chitosan can also be employed in preventing the putrefaction of water and in the production of antimicrobial fibers.

Abstract

A process for producing a chitin derivative and/or a chitosan derivative that have a crosslinked structure, which comprises irradiating a paste of a mixture consisting of 100 parts by weight of a chitin derivative and/or a chitosan derivative and 3˜1,000 parts by weight of purified water.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates to a process for producing chitin derivatives and/or chitosan derivatives with a crosslinked structure by adding purified water to chitin derivatives and/or chitosan derivatives, kneading the mixture well and applying an ionizing radiation to the kneaded mixture. The chitin derivatives having a crosslinked structure are hydrogels and the chitosan derivatives having a crosslinked structure are hydrogels having antimicrobial activity. [0001]
  • Hydrogels can hold a large amount of water within the three-dimensional network structure generated by crosslinking with radiation. The retained water will not seep out under slight pressure. Such hydrogels are already in use as disposable diapers and as humectants in cosmetics. [0002]
  • Carboxymethyl-chitin (CM-chitin) and carboxymethyl-chitosan (CM-chitosan), if they are irradiated in either a solid form or as a dilute (≦5%) aqueous solution, preferentially undergo decomposition and no hydrogels will form. If they are irradiated in a concentrated paste form (that will not flow out if the container is tilted), a crosslinked structure can be introduced and the resulting gel will absorb water upon immersion in it to become a hydrogel. In the case of a CM-chitosan hydrogel, it has been found to have a new feature, antimicrobial activity, in spite of it being a hydrogel. [0003]
  • Hydrogels can be easily obtained by applying an ionizing radiation to aqueous solutions of polyethylene oxides, poly(vinyl alcohol), polyacrylamides, polyvinylpyrrolidone, etc. Being capable of absorbing and holding a large amount of water, hydrogels are used in medical and cosmetics fields as sanitary products (e.g. disposable diapers) and humectants. These hydrogels are primarily made of poly(sodium acrylate) based materials. Used hydrogels are disposed of by incineration, so if they are treated massively, the temperature in the incinerator will drop to cause a potential problem of producing dioxins. Attempts are therefore being made to use hydrogels that decompose in the soil to exert no environmental impact, as exemplified by poly(sodium glutamate) and poly(sodium aspartate) having irradiation-generated crosslinks. [0004]
  • Formaldehyde and glutaraldehyde are conventionally used to create chemical crosslinks in chitin and chitosan. However, since the aldehydes contaminate the working environment or the residual aldehydes may irritate the skin, a safer method of crosslinking is desired. [0005]
  • Hydrogels produced by crosslinking water-soluble polymers absorb a large amount of water, so they are used in sanitary products such as disposable diapers. Typically, zeolite incorporating antimicrobes such as silver are added as an antimicrobial agent. However, accumulation of silver is not preferred from the viewpoint of health. It is therefore required to develop high-molecular weight polymers that themselves have antimicrobial activity. [0006]
  • Chitosan has positive electric charges, so they bind to negatively charged microorganisms and exhibit antimicrobial activity to inhibit microbial growth. Thus, the applicable scope of chitin and chitosan which are currently discarded will expand and their added value will further increase if a safer method of their crosslinking is found and if hydrogels that themselves have antimicrobial activity are developed. However, chitin and chitosan have no compatible solvents and if they are irradiated in a solid state, marked decomposition will occur. Therefore, chitin and chitosan are difficult to process into films or fibers and it is also difficult to crosslink them by radiation. [0007]
  • If the hydrogen in hydroxyl groups in chitin and chitosan is replaced by a hydroxyl or carboxyl group, intermolecular hydrogen bonds sufficiently weaken that chitin and chitosan willcome to dissolve in water. As a result of their intensive studies, the present inventors found that carboxymethylated chitin and chitosan (chitin and chitosan derivatives) could be crosslinked when irradiated in a thick paste form. The present invention has been accomplished on the basis of this finding. It was also revealed that CM-chitosan was a hydrogel having a unique feature of presenting antimicrobial activity. [0008]
  • SUMMARY OF THE INVENTION
  • Water-soluble chitin and chitosan derivatives, when exposed to radiation either in a solid state or as a dilute (≦5%) aqueous solution, preferentially undergo decomposition, so it has been difficult to process them by radiation-induced crosslinking. The present inventors added purified water to chitin and chitosan derivatives and kneaded them well to prepare a thick paste and successfully crosslinked the paste by applying an ionizing radiation. Interestingly, the hydrogel of CM-chitosan derivative obtained by crosslinking has antimicrobial activity.[0009]
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1A is a photo showing that a PVA hydrogel has no antimicrobial activity against [0010] E. coli;
  • FIG. 1B is a photo showing the antimicrobial activity of a CM-chitosan hydrogel with a gel fraction of 40% against E. coli; and [0011]
  • FIG. 1C is a photo showing the antimicrobial activity of a CM-chitosan hydrogel with a gel fraction of 25% against [0012] E. coli.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The hydrogels of chitin and chitosan derivatives according to the invention are synthesized by the following method. Chitin and chitosan derivatives having different degrees of substitution are kneaded well with purified water to make a concentrated paste that is thick enough not to flow out if the container is tilted. The paste is put into a poly(vinylidene chloride) bag, evacuated, heat sealed and exposed to electron beams. Before irradiation, the paste was soft but upon irradiation, it turned to a rubbery and elastic gel. In order to perform radiation-induced crosslinking, the paste must have a concentration of at least 10%, preferably between 30% and 50%. In a solid state or at concentrations lower than 10%, decomposition occurs preferentially and there is no visible gel formation by crosslinking. Solubility in water varies with the degree of substitution and the higher the substitution, the thicker the paste that can be prepared and the faster its preparation. [0013]
  • The ionizing radiation can be γ-rays, electron beams or X-rays. The crosslinking dose is 0.5˜1,000 kGy, preferably 5˜300 kGy. [0014]
  • Any chitin and chitosan derivatives that are soluble in water can be used in the invention. Higher degrees of substitution are preferred since they increase the affinity for water and, hence, provide thicker pastes. The most preferred degree of substitution is 0.3˜0.9. Chitin is extracted from the outer covering of crustaceans such as shrimps and crabs by deproteinization and chitosan is obtained from chitin by deacetylation. Since chitin and chitosan are comparatively cheap materials, they are preferred as materials for the synthesis of derivatives. [0015]
  • Examples of the chitin derivatives of the invention include CM-chitin, carboxyethyl-chitin, methyl-chitin, ethyl-chitin, hydroxyethyl-chitin, hydroxypropyl-chitin, oxidized chitin, acetyl-chitin, aminoalkyl-chitin and allyl-chitin. Examples of the chitosan derivatives of the invention include CM-chitosan, carboxyethyl-chitosan, methyl-chitosan, ethyl-chitosan, hydroxyethyl-chitosan, hydroxypropyl-chitosan, oxidized chitosan, acetyl-chitosan, aminoalkyl-chitosan and allyl-chitosan. [0016]
  • For the purpose of industrial production, two preferred examples of the ionizing radiation are γ-rays from cobalt-60 and electron beams from an accelerator. The most preferred electron accelerator is one of medium to high energy types that have acceleration voltages of at least 1 MeV and can irradiate thick sheets. If a yet-to-be irradiated sample is pressurized to form a film, even the electron beams from a low-energy electron accelerator having an acceleration voltage of less than 1 MeV can penetrate the sample and the intended gel can be formed by radiation-induced crosslinking. During irradiation, oxygen has little effect on crosslinking; however, in order to ensure that water will not evaporate and the density of crosslinks will not decrease during irradiation, the top surface of the sample is desirably covered with a film of plastics such as polyester. [0017]
  • Gel fraction is determined as follows. The gel formed by irradiation is freeze-dried and put into a vacuum dryer where it is dried at 50° C. until its weight becomes constant. The dried sample is put into a cage of stainless steel wire having a fineness of 200 mesh and immersed in a large volume of water for 48 hours. The uncrosslinked soluble component of the sample has moved into the aqueous phase, leaving only the gelled component in the cage. The stainless steel cage holding the gel is immersed in methanol for 1 hour, recovered and then dried at 50° C. for 24 hours. Gel fraction is calculated by the following equation: [0018]
  • Gel fraction (%)=(gel weight without soluble component/initial dry weight)×100
  • To determine the degree of swell, an irradiated paste of sample is immersed in a large volume of water for 48 hours and the obtained gel is freeze-dried and immersed in purified water; the degree of swell is expressed in grams of the purified water absorbed by one gram of the dry gel. [0019]
  • The antimicrobial activity of the hydrogel is determined as follows. An irradiated paste of sample is immersed in purified water for 48 hours in order to remove the uncrosslinked sol. The remaining gel is cut to a specified size and put into a Petri dish containing an agar medium plated with [0020] E. coli. As time passes, E. coli grows. A clear zone forming around the hydrogel indicates an inhibition of E. coli growth and one may conclude that the hydrogel has antimicrobial activity.
  • Chitosan has antimicrobial activity whose intensity increases if the molecular weight of chitosan is decreased by irradiation. However, chitosan dissolves only in dilute acids and cannot be easily processed into hydrogel or sheet. According to the invention, a hydrogel having antimicrobial activity could successfully be produced from chitosan derivatives by crosslinking them with radiation. By radiation-induced crosslinking, the hydrogel can be obtained in blocks, sheets or various other shapes and may find use in the following applications. [0021]
  • In the medical field, the hydrogel of chitosan derivatives or their blends with other hydrogels may be used as wound dressings that are applied to cover wounds due to injury or burn and promote their healing. Wound dressings of wet type have recently been put on the market since burn and wounds such as bedsores of the elderly can heal rapidly in a wet environment and the healed wound has a smooth surface. The wound dressing using the hydrogel of chitosan derivatives according to the invention is different from the conventional wet type wound dressing since the hydrogel itself has antimicrobial activity and there is no need to add any antimicrobes. [0022]
  • The antimicrobial hydrogel of the invention can be gel spun into fibers having antimicrobial activity. The hydrogel may be deprived of water by evaporation and can subsequently be shaped into a film, which is attached to the surfaces of various substrates to thereby make antimicrobial articles that can prevent the growth of molds and other deleterious microorganisms. Thus, the antimicrobial hydrogel of the invention has potential application in various fields. [0023]
  • The following examples and comparative examples are provided for further illustrating the present invention. [0024]
  • EXAMPLE 1
  • CM-chitin was used; it had a degree of substitution of 0.49, a molecular weight of 2.82×10[0025] 4 and a degree of deacetylation of 17.7%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 10, 20, 30, 40 and 50%, which were irradiated with electron beams to a dose of 50 kGy. The results are shown in Table 1, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel. For crosslinking, the CM-chitin preferably has a concentration of 20-40%.
    TABLE 1
    Gel fractions and the degrees of swell in the
    case of exposing 50 kGy of electron beams to
    CM-chitin (degree of substitution: 0.49) at
    varying concentrations
    Concentration (%) 10 20 30 40 50
    of CM-chitin
    Gel fraction (%) 31 48 50 52 28
    Degree of swell 111 56 34 21 93
    (g H2O/1 g dry gel
  • EXAMPLE 2
  • CM-chitin was used; it had a degree of substitution of 0.83, a molecular weight of 2.93×10[0026] 4 and a degree of deacetylation of 31.4%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 10, 20, 30, 40 and 50%, which were irradiated with electron beams to a dose of 50 kGy. The results are shown in Table 2, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel. For crosslinking, the CM-chitin preferably has a concentration of 20˜40%.
    TABLE 2
    Gel fractions and the degrees of swell in the
    case of exposing 50 kGy of electron beams to
    CM-chitin (degree of substitution: 0.83) at
    varying concentrations
    Concentration (%) 10 20 30 40 50
    of CM-chitin
    Gel fraction (%) 41 52 59 61 46
    Degree of swell 148 58 20 14 120
    (g H2O/1 g dry gel
  • COMPARATIVE EXAMPLE 1
  • Two kinds of CM-chitin were used; one of them had a degree of substitution of 0.49, a molecular weight of 2.82×10[0027] 4 and a degree of deacetylation of 17.7%; the other had a degree of substitution of 0.83, a molecular weight of 2.93×104 and a degree of deacetylation of 31.4%. Each sample was exposed to electron beams from an accelerator in two states, solid at room temperature and as a dilute (≦5%) aqueous solution, until the dose was 200 kGy. In either case, the molecular weights of the samples decreased to such an extent that they were readily soluble in water; however, no water-insoluble gel component formed and no crosslinking occurred under the conditions employed.
  • EXAMPLE 3
  • CM-chitosan was used; it had a degree of substitution of 0.91, a molecular weight of 3.1×10[0028] 4 and a degree of deacetylation of 84.0%. It was kneaded well with varying volumes of purified water to make samples in paste (grease) form at concentrations of 20, 25, 35 and 50%, which were irradiated with electron beams to a dose of 100 kGy. The results are shown in Table 3, from which it is clear that by irradiating the paste, a water-insoluble gel formed and crosslinking occurred. Upon immersion in a large volume of water, the crosslinked CM-chitin swelled to form a hydrogel. For crosslinking, the CM-chitosan preferably has a concentration of 25-35%.
  • A test was conducted to evaluate the antimicrobial activity of a CM-chitosan hydrogel that was prepared by exposing electron beams to a paste of 35% CM-chitosan to a dose of 150 kGy. The sample was immersed in purified water for 48 hours to remove the sol which was a soluble component. The thus prepared CM-chitosan hydrogel had a gel fraction of 40%. [0029]
  • The hydrogel was cut to a disk with a diameter of 10 mm and placed on an agar medium plated with 1×10[0030] 6 E. coli cells/mL which were cultured at 37° C. As FIG. 1B shows, a clear zone about 5 mm wide formed around the hydrogel by inhibiting the growth of E. coli; the CM-chitosan hydrogel obviously had antimicrobial activity.
    TABLE 3
    Gel fractions and the degrees of swell in the
    case of exposing 100 kGy of electron beams to
    CM-chitosanat varying concentrations
    Concentration (%) 20 25 35 50
    of CM-chitosan
    Gel fraction (%) 36 40 41 43
    Degree of swell 126 86 58 117
    (g H2O/1 g dry gel
  • EXAMPLE 4
  • CM-chitosan was used; it had a degree of deacetylation of 84.0%, a degree of substitution (degree of carboxymethylation) of 0.91 and a viscosity average molecular weight of 3.1×10[0031] 4. A CM-chitosan hydrogel was prepared by exposing electron beams to a paste of 35% CM-chitosan to a dose of 80 kGy. The sample was immersed in purified water for 48 hours to remove the sol which was a soluble component. The thus prepared CM-chitosan hydrogel had a gel fraction of 25%.
  • As in Example 3, the hydrogel was cut to a disk with a diameter of 10 mm and placed on an agar medium plated with 1×10[0032] 6 E. coli cells/mL which were cultured at 37° C. As FIG. 1C shows, a clear zone about 5 mm wide formed around the hydrogel by inhibiting the growth of E. coli. Growth of E. coli occurred in areas of the medium other than around the hydrogel disk.
  • COMPARATIVE EXAMPLE 2
  • CM-chitosan was used; it had a degree of substitution of 0.91, a molecular weight of 3.1×10[0033] 4 and a degree of deacetylation of 84.0%. The sample was exposed to electron beams from an accelerator in two states, solid at room temperature and as a dilute (≦10%) aqueous solution, until the dose was 300 kGy. In either case, the molecular weight of the sample decreased to such an extent that it was readily soluble in water; however, no water-insoluble gel component formed and no crosslinking occurred under the conditions employed.
  • COMPARATIVE EXAMPLE 3
  • A hydrogel prepared by irradiating an aqueous solution of 10% poly(vinyl alcohol) was tested for its antimicrobial activity. A disk of the PVA hydrogel with a diameter of 10 mm was placed on an agar medium plated with 1×10[0034] 6 E. coli cells/mL which were cultured at 37° C. As FIG. 1A shows, E. coli grew uniformly around the hydrogel with the lapse of time. No clear zone formed around the hydrogel, clearly demonstrating the absence of its antimicrobial activity. The white bands in the center of FIG. 1A are due to the reflection of light from the clear hydrogel that occurred when the picture was taken.
  • Speaking of potential applications of the invention, the CM-chitin has acetyl groups, so after being crosslinked, it can be reacted with such acetyl groups to create a hydrogel having a new property. The CM-chitosan hydrogel is a unique gel which itself has antimicrobial activity. In the medical field, the CM-chitosan hydrogel can be used as a wound dressing which, when applied to a wound, can prevent the ingress of germs to promote the healing of the wound. The CM-chitosan can also be employed in preventing the putrefaction of water and in the production of antimicrobial fibers. [0035]

Claims (8)

What is claimed is:
1. A process for producing a chitin derivative and/or a chitosan derivative that have a crosslinked structure, which comprises irradiating a paste of a mixture consisting of 100 parts by weight of a chitin derivative and/or a chitosan derivative and 3˜1,000 parts by weight of purified water.
2. The process according to claim 1, wherein the chitin derivative and/or chitosan derivative as the starting material is carboxyalkyl-chitin, carboxyalkyl-chitosan, hydroxyalkyl-chitin, hydroxyalkyl-chitosan, alkyl-chitin, alkyl-chitosan or a mixture that have at least one hydroxy or carboxyl group per gulcose unit.
3. The process according to claim 1, wherein a total of at least 20 hydroxyl groups and carboxyl groups in the chitin derivative and/or chitosan derivative as the starting material form an alkali metal salt, an ammonium salt or an amine salt.
4. The process according to claim 1, wherein the chitin derivative and/or chitosan derivative have an average degree of substitution of at least 0.01.
5. The process according to claim 1, wherein the viscosity of the paste of mixture increases to a value above 1.0 upon irradiation, with 1.0 being assumed as the value before irradiation.
6. The process according to claim 1, wherein the irradiation is by exposure to an ionizing radiation to a dose of at least 0.5 kGy.
7. The process according to claim 1, wherein the chitin derivative and/or chitosan derivative having a crosslinked structure has absorbed purified water in a volume at least 5 times as much as its own weight.
8. The process according to claim 1, wherein a hydrogel and a dried film of the chitosan derivative having a crosslinked structure has antimicrobial activity.
US10/305,108 2001-11-28 2002-11-27 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure Abandoned US20030125532A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/028,203 US7307157B2 (en) 2001-11-28 2005-01-04 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001362131A JP3947391B2 (en) 2001-11-28 2001-11-28 Method for producing chitin derivative and / or chitosan derivative having bridge structure
JP2001-362131 2001-11-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/028,203 Continuation US7307157B2 (en) 2001-11-28 2005-01-04 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure

Publications (1)

Publication Number Publication Date
US20030125532A1 true US20030125532A1 (en) 2003-07-03

Family

ID=19172682

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/305,108 Abandoned US20030125532A1 (en) 2001-11-28 2002-11-27 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure
US11/028,203 Expired - Fee Related US7307157B2 (en) 2001-11-28 2005-01-04 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/028,203 Expired - Fee Related US7307157B2 (en) 2001-11-28 2005-01-04 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure

Country Status (2)

Country Link
US (2) US20030125532A1 (en)
JP (1) JP3947391B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031474A1 (en) * 2005-08-05 2007-02-08 Tayot Jean L Implantable preparations
CN100389145C (en) * 2006-09-29 2008-05-21 北京大学 Water gel containing natural high molecule and its radiation preparing method
US20120164208A1 (en) * 2009-07-13 2012-06-28 Nanyang Technological University Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
WO2012152877A1 (en) * 2011-05-12 2012-11-15 Lantor (Uk) Limited Process and dressing
CN105115927A (en) * 2015-09-11 2015-12-02 青岛科技大学 Method for determining substitution degree of hydroxypropyl chitosan
CN105158193A (en) * 2015-09-11 2015-12-16 青岛科技大学 Testing method for degree of substitution of hydroxypropyl chitosan
CN115873145A (en) * 2023-03-08 2023-03-31 山东东瑞生物技术有限公司 Preparation method of carboxymethyl chitosan
CN116942425A (en) * 2023-07-19 2023-10-27 东莞苏氏卫生用品有限公司 Baby diaper containing fibers with strong water absorbability and production method thereof

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100468A1 (en) * 2004-03-31 2005-10-27 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Temperature-responsiive composition and hydrogel thereof
JP4650391B2 (en) * 2006-10-26 2011-03-16 株式会社Nhvコーポレーション Boron / germanium adsorbent and its production method
EP2121048B9 (en) 2007-02-19 2016-02-24 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
FR2918565B1 (en) 2007-07-12 2009-10-30 Biopharmex Holding Sa CARBOXYALKYLAMIDE HYDROGEL OF CHITOSAN, ITS PREPARATION AND ITS COSMETIC AND DERMATOLOGICAL USE
GB0719065D0 (en) * 2007-09-29 2007-11-07 Smith & Nephew coalescing materials
CL2008000156A1 (en) * 2008-01-18 2008-08-01 Igloo Zone Chile S A STABLE HYDROPHYLE GEL BASED ON A POLYMER FOR TOPICAL APPLICATION BECAUSE IT INCLUDES DISSOLVED CHITOSANE IN A SOLVENT; PROCESS TO OBTAIN THE GEL FOR TOPICAL USE BEFORE MENTIONED; USE OF THE GEL.
KR20100129263A (en) * 2008-02-06 2010-12-08 도레이 카부시키가이샤 Aqueous dispersion containing polysaccharide particulate gel and method for producing the same
JP2010121028A (en) * 2008-11-19 2010-06-03 Ina Food Industry Co Ltd Modified xanthan gum, modified gum arabic, and modified tamarind seed gum, and method for cross-linking xanthan gum, gum arabic, and tamarind seed gum
CN101935364B (en) * 2009-09-15 2012-05-02 上海交通大学医学院附属第九人民医院 Quaternary ammonium salt of chitosan and application thereof
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
WO2012142581A1 (en) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
JP2015048436A (en) * 2013-09-03 2015-03-16 公立大学法人福井県立大学 Chitin inclusion derived from organism for improving disease resistance of plant, application method thereof, and manufacturing method thereof
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
CN104027833B (en) * 2014-06-04 2015-11-18 武汉纺织大学 A kind of preparation method of aquagel dressing
CN111406074A (en) * 2018-03-14 2020-07-10 麦克沃克斯股份有限公司 Deacetylation and cross-linking of chitin and chitosan for tunable properties in fungal materials and composites thereof
US20220119576A1 (en) * 2020-10-20 2022-04-21 Qatar University Radiolytic method of preparing gels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US6124273A (en) * 1995-06-09 2000-09-26 Chitogenics, Inc. Chitin hydrogels, methods of their production and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5694322A (en) 1979-12-27 1981-07-30 Mitsubishi Rayon Co Ltd Contact lens
JP2855307B2 (en) * 1992-02-05 1999-02-10 生化学工業株式会社 Photoreactive glycosaminoglycans, cross-linked glycosaminoglycans and methods for producing them
WO2000027889A1 (en) * 1998-11-10 2000-05-18 Netech Inc. Functional chitosan derivative
US6566345B2 (en) * 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US6124273A (en) * 1995-06-09 2000-09-26 Chitogenics, Inc. Chitin hydrogels, methods of their production and use

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031474A1 (en) * 2005-08-05 2007-02-08 Tayot Jean L Implantable preparations
US7709017B2 (en) * 2005-08-05 2010-05-04 Khorionyx Implantable preparations
CN100389145C (en) * 2006-09-29 2008-05-21 北京大学 Water gel containing natural high molecule and its radiation preparing method
US20140193476A1 (en) * 2009-07-13 2014-07-10 Nanyang Technological University Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
US8709470B2 (en) * 2009-07-13 2014-04-29 Menicon Co., Ltd. Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
US20120164208A1 (en) * 2009-07-13 2012-06-28 Nanyang Technological University Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
US9199000B2 (en) * 2009-07-13 2015-12-01 Nanyang Technological University Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
US9750847B2 (en) 2009-07-13 2017-09-05 Nanyang Technological University Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
WO2012152877A1 (en) * 2011-05-12 2012-11-15 Lantor (Uk) Limited Process and dressing
CN105115927A (en) * 2015-09-11 2015-12-02 青岛科技大学 Method for determining substitution degree of hydroxypropyl chitosan
CN105158193A (en) * 2015-09-11 2015-12-16 青岛科技大学 Testing method for degree of substitution of hydroxypropyl chitosan
CN115873145A (en) * 2023-03-08 2023-03-31 山东东瑞生物技术有限公司 Preparation method of carboxymethyl chitosan
CN116942425A (en) * 2023-07-19 2023-10-27 东莞苏氏卫生用品有限公司 Baby diaper containing fibers with strong water absorbability and production method thereof

Also Published As

Publication number Publication date
JP3947391B2 (en) 2007-07-18
US20050113773A1 (en) 2005-05-26
JP2003160602A (en) 2003-06-03
US7307157B2 (en) 2007-12-11

Similar Documents

Publication Publication Date Title
US7307157B2 (en) Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure
Kundu et al. Cellulose hydrogels: Green and sustainable soft biomaterials
RU2748184C2 (en) Composition for wound dressings
DE69918707T2 (en) Wound bandage made of hydrogel with quaternary amines that is inherently micro-killing
DE69938612T2 (en) FUNCTIONAL CHITOSANDERIVATE
CN109513039B (en) Antibacterial hydrogel dressing containing imidazole bromide salt and preparation method and application thereof
Tahtat et al. Influence of some factors affecting antibacterial activity of PVA/Chitosan based hydrogels synthesized by gamma irradiation
DE3128815A1 (en) POLYMER COMPOSITE MATERIAL, ITS PRODUCTION AND USE
Mohamed et al. Synthesis and characterization of antibacterial semi-interpenetrating carboxymethyl chitosan/poly (acrylonitrile) hydrogels
WO2018167623A1 (en) Process for the preparation of antimicrobial hydrogel
Park et al. Preparation and evaluation of β-glucan hydrogel prepared by the radiation technique for drug carrier applications
KR100440239B1 (en) Method for the preparation of hydrogels for wound dressings
JP2008144007A (en) Method for producing gel using polysaccharide as raw material
El-Din et al. Biological applications of nanocomposite hydrogels prepared by gamma-radiation copolymerization of acrylic acid (AAc) onto plasticized starch (PLST)/montmorillonite clay (MMT)/chitosan (CS) blends
JP2004059926A (en) Starch hydrogel
JPH06322358A (en) New biodedgradable high water absorbent and its production
KR100333317B1 (en) Method for preparation of hydrogels dressings by using radiation
KR101362286B1 (en) Method of manufacturing chitosan/poly(vinylachol) hybrid nanofibers with insolubility by water
Wikanta et al. Synthesis of polyvinyl alcohol-chitosan hydrogel and study of its swelling and antibacterial properties
US6617448B2 (en) Process for producing grosslinked starch derivatives and crosslinked starch derivatives produced by the same
JP4220832B2 (en) Method for producing heat-resistant molded body made of gelatin
WO2010067378A2 (en) Hydrogel composition
Tranquilan-Aranilla et al. Properties and Potential Applications of Carboxymethyl-kappa-carrageenan Hydrogels Crosslinked by Gamma Radiation.
CN115010958A (en) Hydrogel for promoting wound healing and preparation method and application thereof
JP3502879B2 (en) Novel biodegradable superabsorbent and its production method

Legal Events

Date Code Title Description
AS Assignment

Owner name: JAPAN ATOMIC ENERGY RESEARCH INSTITUTE, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YOSHII, FUMIO;NAGASAWA, NAOTSUGU;KUME, TAMIKAZU;AND OTHERS;REEL/FRAME:013547/0857

Effective date: 20021120

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION